Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 903  

    Article Cited by others


Dosimetric Considerations in Radioimmunotherapy and Systemic Radionuclide Therapies: A Review

Loke Kelvin S.H, Padhy Ajit K, Ng David C.E, Goh Anthony S.W, Divgi Chaitanya

Year : 2011| Volume: 10| Issue : 2 | Page no: 122-138

   This article has been cited by
1 Quantitative PET in the 2020s: a roadmap
Steven R Meikle,Vesna Sossi,Emilie Roncali,Simon R Cherry,Richard Banati,David Mankoff,Terry Jones,Michelle James,Julie Sutcliffe,Jinsong Ouyang,Yoann Petibon,Chao Ma,Georges El Fakhri,Suleman Surti,Joel S Karp,Ramsey D Badawi,Taiga Yamaya,Go Akamatsu,Georg Schramm,Ahmadreza Rezaei,Johan Nuyts,Roger Fulton,André Kyme,Cristina Lois,Hasan Sari,Julie Price,Ronald Boellaard,Robert Jeraj,Dale L Bailey,Enid Eslick,Kathy P Willowson,Joyita Dutta
Physics in Medicine & Biology. 2021; 66(6): 06RM01
[Pubmed]  [Google Scholar] [DOI]
2 Radiopharmaceutical Chemistry and Drug Development—Whatćs Changed?
Charles A. Kunos,David A. Mankoff,Michael K. Schultz,Stephen A. Graves,Daniel A. Pryma
Seminars in Radiation Oncology. 2021; 31(1): 3
[Pubmed]  [Google Scholar] [DOI]
3 Evaluation of Safety and Dosimetry of 177Lu-DOTA-ZOL for Therapy of Bone Metastases
René Fernández,Elisabeth Eppard,Wencke Lehnert,Luis David Jiménez-Franco,Cristian Soza-Ried,Matías Ceballos,Jessica Ribbeck,Andreas Kluge,Frank Rösch,Marian Meckel,Konstantin Zhernosekov,Vasko Kramer,Horacio Amaral
Journal of Nuclear Medicine. 2021; 62(8): 1126
[Pubmed]  [Google Scholar] [DOI]
4 B7-H3-targeted Radioimmunotherapy of Human Cancer
Benjamin B. Kasten,Soldano Ferrone,Kurt R. Zinn,Donald J. Buchsbaum
Current Medicinal Chemistry. 2020; 27(24): 4016
[Pubmed]  [Google Scholar] [DOI]
5 Evaluation of [131I]I- and [177Lu]Lu-DTPA-A11 Minibody for Radioimmunotherapy in a Preclinical Model of PSCA-Expressing Prostate Cancer
Wen-Ting K Tsai,Kirstin A Zettlitz,Magnus Dahlbom,Robert E Reiter,Anna M Wu
Molecular Imaging and Biology. 2020;
[Pubmed]  [Google Scholar] [DOI]
6 Prostate Cancer Theranostics - An Overview
Diane Abou,Nadia Benabdallah,Wen Jiang,Lu Peng,Hanwen Zhang,Alexandria Villmer,Mark S. Longtine,Daniel L. J. Thorek
Frontiers in Oncology. 2020; 10
[Pubmed]  [Google Scholar] [DOI]
7 Preclinical Dosimetry, Imaging, and Targeted Radionuclide Therapy Studies of Lu-177-Labeled Albumin-Binding, PSMA-Targeted CTT1403
Xiaoxi Ling,Joseph D. Latoche,Cindy J. Choy,Brenda F. Kurland,Charles M. Laymon,Yijen Wu,Nathan Salamacha,Ding Shen,Jonathan J. Geruntho,Lora H. Rigatti,Hillarie P. Windish,Beatrice Langton-Webster,Clifford E. Berkman,Carolyn J. Anderson
Molecular Imaging and Biology. 2019;
[Pubmed]  [Google Scholar] [DOI]
8 Trifunctional PSMA-targeting constructs for prostate cancer with unprecedented localization to LNCaP tumors
James Kelly,Alejandro Amor-Coarasa,Shashikanth Ponnala,Anastasia Nikolopoulou,Clarence Williams,David Schlyer,Yize Zhao,Dohyun Kim,John W. Babich
European Journal of Nuclear Medicine and Molecular Imaging. 2018;
[Pubmed]  [Google Scholar] [DOI]
9 Radioimmunotherapy of solid tumors: Approaches on the verge of clinical application
Mark D. Bartholomä
Journal of Labelled Compounds and Radiopharmaceuticals. 2018;
[Pubmed]  [Google Scholar] [DOI]
10 Evaluation of sequential SPECT and CT for targeted radionuclide therapy dosimetry
Tiantian Li,Nien-Yun Wu,Na Song,Greta S. P. Mok
Annals of Nuclear Medicine. 2017;
[Pubmed]  [Google Scholar] [DOI]
11 Nuclear Medicine Training: What Now?
David Mankoff,Daniel A. Pryma
Journal of Nuclear Medicine. 2017; 58(10): 1536
[Pubmed]  [Google Scholar] [DOI]
12 Dosimetric analysis of 177Lu-DOTA-rituximab in patients with relapsed/refractory non-Hodgkin’s lymphoma
Madhav P. Yadav,Suhas Singla,Parul Thakral,Sanjana Ballal,Chandrasekhar Bal
Nuclear Medicine Communications. 2016; 37(7): 735
[Pubmed]  [Google Scholar] [DOI]
13 An automatic delineation method for bone marrow absorbed dose estimation in 89Zr PET/CT studies
N.E. Makris,R. Boellaard,C.W. Menke,A.A. Lammertsma,M.C. Huisman
EJNMMI Physics. 2016; 3(1)
[Pubmed]  [Google Scholar] [DOI]
14 Relevance of radiobiological concepts in radionuclide therapy of cancer
Chandan Kumar,Neena Shetake,Sejal Desai,Amit Kumar,Grace Samuel,Badri N. Pandey
International Journal of Radiation Biology. 2016; : 1
[Pubmed]  [Google Scholar] [DOI]
15 Involvement of let-7 microRNA for the therapeutic effects of Rhenium-188-embedded liposomal nanoparticles on orthotopic human head and neck cancer model
Liang-Ting Lin,Chun-Yuan Chang,Chih-Hsien Chang,Hsin-Ell Wang,Shih-Hwa Chiou,Ren-Shyan Liu,Te-Wei Lee,Yi-Jang Lee
Oncotarget. 2016; 7(40): 65782
[Pubmed]  [Google Scholar] [DOI]
16 Imaging Predictors of Elevated Lung Shunt Fraction in Patients Being Considered for Yttrium-90 Radioembolization
Olufoladare G. Olorunsola,Maureen P. Kohi,Spencer C. Behr,Pallav K. Kolli,Andrew G. Taylor,Ricky T. Tong,Jeanne M. LaBerge,Robert K. Kerlan,Nicholas Fidelman
Journal of Vascular and Interventional Radiology. 2015; 26(10): 1472
[Pubmed]  [Google Scholar] [DOI]
17 Biodistribution and radiation dosimetry of radioiodinated hypericin as a cancer therapeutic
International Journal of Oncology. 2014; 44(3): 819
[Pubmed]  [Google Scholar] [DOI]
18 Characteristics of Primary and Secondary Hepatic Malignancies Associated with Hepatopulmonary Shunting
Ron C. Gaba,Sean P. Zivin,Mark S. Dikopf,Ahmad Parvinian,Leigh C. Casadaban,Yang Lu,James T. Bui
Radiology. 2014; : 131969
[Pubmed]  [Google Scholar] [DOI]
19 An overview of translational (radio)pharmaceutical research related to certain oncological and non-oncological applications
Marlein Miranda Cona
World Journal of Methodology. 2013; 3(4): 45
[Pubmed]  [Google Scholar] [DOI]
20 Therapeutic Efficacy of C-Kit-Targeted Radioimmunotherapy Using 90Y-Labeled Anti-C-Kit Antibodies in a Mouse Model of Small Cell Lung Cancer
Chisato Yoshida,Atsushi B. Tsuji,Hitomi Sudo,Aya Sugyo,Tatsuya Kikuchi,Mitsuru Koizumi,Yasushi Arano,Tsuneo Saga,Javier S. Castresana
PLoS ONE. 2013; 8(3): e59248
[Pubmed]  [Google Scholar] [DOI]
21 The Role of p53 in Combination Radioimmunotherapy with 64Cu-DOTA-Cetuximab and Cisplatin in a Mouse Model of Colorectal Cancer
Yunjun Guo,Jesse J. Parry,Richard Laforest,Buck E. Rogers,Carolyn J. Anderson
Journal of Nuclear Medicine. 2013; 54(9): 1621
[Pubmed]  [Google Scholar] [DOI]


Read this article